Published in Obesity and Diabetes Week, July 10th, 2006
This double-blind, placebo-controlled study of 204 patients showed that patients treated with Testim experienced a statistically significant improvement in serum testosterone levels (p less than or equal to 0.001) compared to those receiving placebo. Patients in the Testim treatment group also experienced a statistically significant increase in lean body mass (muscle mass) (p=0.026) and decrease in fat mass (p less than or equal to 0.001) compared to the control group, confirming...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.